• 中山大學(xué)孫逸仙紀(jì)念醫(yī)院肝膽胰外科（廣東廣州 510120）;

引用本文： 張磊,陳積圣. 自體脾移植及食管橫斷吻合術(shù)治療門靜脈高壓癥的臨床與基礎(chǔ)研究：可供選擇的一種新療法的30年觀察. 中國普外基礎(chǔ)與臨床雜志, 2013, 20(1): 13-17. doi: 復(fù)制

版權(quán)信息： ?四川大學(xué)華西醫(yī)院華西期刊社《中國普外基礎(chǔ)與臨床雜志》版權(quán)所有，未經(jīng)授權(quán)不得轉(zhuǎn)載、改編

1. Liu H， Lee SS. The spleen is a player in portal hypertension[J]. Exp Physiol， 2012， 97(9)：999-1000.
2. Leemans R， Manson W， Snijder JA， et al. Immune response capacity after human splenic autotransplantation：restoration of response to individual pneumococcal vaccine subtypes[J]. Ann Surg， 1999， 229(2)：279-285.
3. Galloway JR， Henderson JM. Managment of variceal bleeding in patients with extrahepatic portal vein thrombosis[J]. Am J Surg， 1990， 160(1)：122-127.
4. Orozco HC， Mercado MA， Chan C， et al. A comparative study of the elective treatment of variceal hemorrhage with beta-blockers，transendoscopic sclerotherapy， and surgery a prospective controlledand randomized trial during 10 years[J]. Ann Surg， 2000， 232(2)：216-219.
5. Zhang H， Chen J， Kaiser GM， et al. The value of partial splenic autotransplantation in patients with portal hypertension a prospective randomized study[J]. Arch Surg， 2002， 137(1)：89-93.
6. Zhang L， Huo JS， Zhang HW， et al. A 26-year clinical observationof splenic auto-transplantation and oesophageal transaction anastomosis： a new treatment strategy in patients with portal hypertension[J]. CMJ (Engl)， 2007， 120 (6)： 452-457.
7. Sirli R， Sporea I， Bota S， et al. Liver elastography for the diagnosis of portal hypertension in patients with liver cirrhosis[J]. Med Ultrasonography， 2012， 14(3)：225-230.
8. Chiam QL， Mansberg R， Bui C， et al. Heterotopic splenicautotransplantation shown on radiolabelled heat-damaged red blood cell scintigraphy[J]. J Inter Med， 2007， 37(4)：276-277.
9. Reverter E， Seijo S， Bosch J. Pulmonary arterial hypertension：an unusual cause of portal hypertension[J]. Gastroenterol Hepatol，2012， 8(6)：408-410.
10. Spence RA， Sloan JM， Johnstone GW， et al. Oesophagealmucosal changes in patients with varices[J]. Gut， 1983， 24(11)：1024-1029.
11. Dzierzbicka K， Wardowska A， Rogalska M， et al. New conjugates of muramyl dipeptide and nor-muramyl dipeptide linked to tuftsin and retro-tuftsin derivatives significantly influence their biological activity[J]. Pharma Reports， 2012， 64(1)：217-223.
12. Petroianu A， Petroianu LPG. Splenic autotransplantation for treatment of portal hypertension[J]. J Can Chir， 2005， 8(5)：382-386.
  1. 1. Liu H， Lee SS. The spleen is a player in portal hypertension[J]. Exp Physiol， 2012， 97(9)：999-1000.
  2. 2. Leemans R， Manson W， Snijder JA， et al. Immune response capacity after human splenic autotransplantation：restoration of response to individual pneumococcal vaccine subtypes[J]. Ann Surg， 1999， 229(2)：279-285.
  3. 3. Galloway JR， Henderson JM. Managment of variceal bleeding in patients with extrahepatic portal vein thrombosis[J]. Am J Surg， 1990， 160(1)：122-127.
  4. 4. Orozco HC， Mercado MA， Chan C， et al. A comparative study of the elective treatment of variceal hemorrhage with beta-blockers，transendoscopic sclerotherapy， and surgery a prospective controlledand randomized trial during 10 years[J]. Ann Surg， 2000， 232(2)：216-219.
  5. 5. Zhang H， Chen J， Kaiser GM， et al. The value of partial splenic autotransplantation in patients with portal hypertension a prospective randomized study[J]. Arch Surg， 2002， 137(1)：89-93.
  6. 6. Zhang L， Huo JS， Zhang HW， et al. A 26-year clinical observationof splenic auto-transplantation and oesophageal transaction anastomosis： a new treatment strategy in patients with portal hypertension[J]. CMJ (Engl)， 2007， 120 (6)： 452-457.
  7. 7. Sirli R， Sporea I， Bota S， et al. Liver elastography for the diagnosis of portal hypertension in patients with liver cirrhosis[J]. Med Ultrasonography， 2012， 14(3)：225-230.
  8. 8. Chiam QL， Mansberg R， Bui C， et al. Heterotopic splenicautotransplantation shown on radiolabelled heat-damaged red blood cell scintigraphy[J]. J Inter Med， 2007， 37(4)：276-277.
  9. 9. Reverter E， Seijo S， Bosch J. Pulmonary arterial hypertension：an unusual cause of portal hypertension[J]. Gastroenterol Hepatol，2012， 8(6)：408-410.
  10. 10. Spence RA， Sloan JM， Johnstone GW， et al. Oesophagealmucosal changes in patients with varices[J]. Gut， 1983， 24(11)：1024-1029.
  11. 11. Dzierzbicka K， Wardowska A， Rogalska M， et al. New conjugates of muramyl dipeptide and nor-muramyl dipeptide linked to tuftsin and retro-tuftsin derivatives significantly influence their biological activity[J]. Pharma Reports， 2012， 64(1)：217-223.
  12. 12. Petroianu A， Petroianu LPG. Splenic autotransplantation for treatment of portal hypertension[J]. J Can Chir， 2005， 8(5)：382-386.